Literature DB >> 7910452

Risk factors for repeatedly reactive HIV-1 EIA and indeterminate western blots. A population-based case-control study.

C L Celum1, R W Coombs, M Jones, V Murphy, L Fisher, C Grant, L Corey, T Inui, M H Wener, K K Holmes.   

Abstract

OBJECTIVE: Causes of indeterminate results of Western blot testing (IWB) for human immunodeficiency virus (HIV) type 1 include seroconversion, HIV-2 cross-reactivity, and autoimmune disease, but most IWB results remain unexplained. This case-control study assessed risk factors for IWB results, including early HIV infection, other retroviral infection, autoantibodies, and other medical conditions.
DESIGN: Prospective study to determine HIV seroconversion rate, with a case-control design to assess other risk factors for IWB. Cases (persons with one or more repeatedly reactive HIV-1 enzyme immunoassay with IWB), their current sexual partners, and controls (persons with negative enzyme immunoassay and Western blot results) were recruited from blood banks, health department and prenatal clinics, and private providers in Washington and Oregon.
RESULTS: Of 244 cases enrolled, 206 were followed up for 6 months or longer, and six (3.0%; 95% confidence interval [CI], 0.7% to 5.3%) with recent HIV risk behaviors seroconverted. The Western blot banding patterns differed among groups; cases usually had p17 or p24 bands, while controls and cases' sexual partners usually had polymerase bands. Conditional logistic regression indicated that independent risk factors for IWB among male cases and controls were a tetanus booster in the past 2 years (odds ratio, 3.2; 95% CI, 1.2 to 8.6) and sexual contact with a prostitute (odds ratio, 3.0; 95% CI, 1.0 to 9.5). Independent risk factors for women were parity (odds ratio, 1.2; 95% CI, 1.02 to 1.4) and autoantibodies, either rheumatoid factor or antinuclear antibodies (odds ratio, 2.3; 95% CI, 1.03 to 5.6). No cross-reactivity was detected with HIV-2, human T-lymphotrophic virus type 1, feline immunodeficiency or feline leukemia, or bovine immunodeficiency viruses.
CONCLUSIONS: Evaluation of persons with reactive HIV-1 enzyme immunoassays and IWB should include an assessment of HIV risk and other possible risk factors, such as alloimmunization (ie, parity or recent immunization) or autoantibodies (ie, antinuclear antibodies and rheumatoid factor). The relationship of IWB among men who reported sex with prostitutes is intriguing and warrants further study.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7910452

Source DB:  PubMed          Journal:  Arch Intern Med        ISSN: 0003-9926


  12 in total

Review 1.  Frequency, causes, and new challenges of indeterminate results in Western blot confirmatory testing for antibodies to human immunodeficiency virus.

Authors:  Ming Guan
Journal:  Clin Vaccine Immunol       Date:  2007-04-04

2.  Evaluation of Chiron HIV-1/HIV-2 recombinant immunoblot assay.

Authors:  R L Kline; D McNairn; M Holodniy; L Mole; D Margolis; W Blattner; T C Quinn
Journal:  J Clin Microbiol       Date:  1996-11       Impact factor: 5.948

Review 3.  Prevention of perinatal HIV transmission: the Perinatal HIV Hotline perspective.

Authors:  Jess Fogler Waldura
Journal:  Top Antivir Med       Date:  2011 Feb-Mar

4.  Low prevalence rate of indeterminate serological human immunodeficiency virus results among pregnant women from Burkina Faso, West Africa.

Authors:  Dramane Kania; Paulin Fao; Diane Valéa; Clarisse Gouem; Thérèse Kagoné; Hervé Hien; Paulin Somda; Patrice Ouédraogo; Aly Drabo; Sandrine Gampini; Nicolas Méda; Serge Diagbouga; Philippe Van de Perre; François Rouet
Journal:  J Clin Microbiol       Date:  2010-02-03       Impact factor: 5.948

5.  False-positive human immunodeficiency virus enzyme immunoassay results in pregnant women.

Authors:  Laura G Wesolowski; Kevin P Delaney; Margaret A Lampe; Steven R Nesheim
Journal:  PLoS One       Date:  2011-01-27       Impact factor: 3.240

6.  Suppressed cellular alloimmune responses in HIV-exposed seronegative female sex workers.

Authors:  W Jennes; D Evertse; M-Y Borget; B Vuylsteke; C Maurice; J N Nkengasong; L Kestens
Journal:  Clin Exp Immunol       Date:  2006-03       Impact factor: 4.330

7.  Misdiagnosed HIV infection in pregnant women: implications for clinical care.

Authors:  A R Sheon; H E Fox; G Alexander; A Buck; A Higgins; S M McDermott; G Moroso; J Moye; E Pacheco-Acosta
Journal:  Public Health Rep       Date:  1994 Sep-Oct       Impact factor: 2.792

8.  Association of inconclusive sera for human immunodeficiency virus infection with malaria and Epstein-Barr virus infection in Central Africa.

Authors:  Francois-Xavier Mbopi-Keou; Angélique Ndjoyi-Mbiguino; Frédéric Talla; Hélène Péré; Khady Kebe; Mathieu Matta; Maurice Aurelien Sosso; Laurent Bélec
Journal:  J Clin Microbiol       Date:  2013-12-04       Impact factor: 5.948

9.  Alternative algorithms for human immunodeficiency virus infection diagnosis using tests that are licensed in the United States.

Authors:  S M Owen; C Yang; T Spira; C Y Ou; C P Pau; B S Parekh; D Candal; D Kuehl; M S Kennedy; D Rudolph; W Luo; N Delatorre; S Masciotra; M L Kalish; F Cowart; T Barnett; R Lal; J S McDougal
Journal:  J Clin Microbiol       Date:  2008-03-05       Impact factor: 5.948

10.  Evaluation of the rapid immunoassay determine HIV 1/2 for detection of antibodies to human immunodeficiency virus types 1 and 2.

Authors:  G E L van den Berk; P H J Frissen; R M Regez; P J G M Rietra
Journal:  J Clin Microbiol       Date:  2003-08       Impact factor: 5.948

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.